查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386330

临床试验影像市场报告：2030 年趋势、预测与竞争分析

Clinical Trial Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

临床试验成像的趋势和预测

预计到 2030 年，全球临床试验影像市场将达到 21 亿美元，2024 年至 2030 年复合年增长率为 7.6%。该市场的主要驱动力是 CRO 的崛起、製药和生物技术行业的显着增长以及发现药物和治疗方法的研发支出的增加。全球临床试验影像市场的未来前景广阔，为製药公司、生物技术公司、医疗设备製造商、委外研发机构、学术研究机构和政府研究组织提供了机会。

临床试验成像市场洞察

Lucintel 预测，在预测期内，电脑断层扫描仍将是最大的细分市场，部分原因是受託研究机构(CRO) 的不断增加和研发投资的增加。

由于对旨在解决慢性病的新治疗方法和药物的需求不断增加，製药公司仍然是市场上最大的部分。

由于领先的外包公司的存在以及该地区研发的不断增加，预计北美地区在预测期内将出现最高的增长。老年人口增加和慢性病增加等各种因素预计将推动北美市场的发展。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球临床试验影像市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球临床试验影像市场趋势（2018-2023）与预测（2024-2030）
  • 按产品和服务分類的全球临床试验影像市场
    • 软体
    • 服务
  • 按模式分類的全球临床试验影像市场
    • CT检查
    • 磁振造影
    • 超音波
    • 正子断层扫描
    • X射线
    • 心臟超音波图
  • 按治疗领域分類的全球临床试验影像市场
    • 肿瘤学
    • 感染疾病
    • 神经病学
    • CVS
    • 内分泌学
    • 免疫疾病
  • 按最终用途分類的全球临床试验影像市场
    • 製药公司
    • 生技公司
    • 医疗设备製造商
    • 合约研究组织
    • 学术和政府研究机构
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球临床试验影像市场（按地区）
  • 北美临床试验影像市场
  • 欧洲临床试验影像市场
  • 亚太临床试验影像市场
  • 其他区域临床试验影像市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品和服务分類的全球临床试验成像市场成长机会
    • 按模式分類的全球临床试验成像市场成长机会
    • 按治疗领域分類的全球临床试验成像市场成长机会
    • 按最终用途分類的全球临床试验成像市场成长机会
    • 按地区分類的全球临床试验成像市场成长机会
  • 全球临床试验影像市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球临床试验影像市场的产能
    • 全球临床试验影像市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • ICON
  • Biotelemetry
  • Medpace Holdings
  • Biomedical Systems Corporation
  • Bioclinica
  • IXICO
  • Resonance Health
  • Radiant Sage
  • Intrinsic Imaging
  • Cardiovascular Imaging Technologies
简介目录

Clinical Trial Imaging Trends and Forecast

The future of the global clinical trial imaging market looks promising with opportunities in the pharmaceutical company, biotechnology company, medical device manufacturer, contract research organization, academic and government research institute markets. The global clinical trial imaging market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing number of CROs, significantly growing pharmaceutical and biotechnology industries, and increasing R&D spending to discover drugs and therapies.

A more than 150-page report is developed to help in your business decisions.

Clinical Trial Imaging by Segment

The study includes a forecast for the global clinical trial imaging by product & services, modality, therapeutic area, end use, and region.

Clinical Trial Imaging Market by Product & Services [Shipment Analysis by Value from 2018 to 2030]:

  • Software
  • Services

Clinical Trial Imaging Market by Modality [Shipment Analysis by Value from 2018 to 2030]:

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Positron Emission Tomography
  • X-ray
  • Echocardiography

Clinical Trial Imaging Market by Therapeutic Area [Shipment Analysis by Value from 2018 to 2030]:

  • Oncology
  • Infectious Diseases
  • Neurology
  • CVS
  • Endocrinology
  • Immunological Disorder

Clinical Trial Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturer
  • Contract Research Organizations
  • Academic and Government Research Institutes
  • Others

Clinical Trial Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clinical Trial Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clinical trial imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clinical trial imaging companies profiled in this report include-

  • Icon
  • Biotelemetry
  • Medpace Holdings
  • Biomedical Systems Corporation
  • Bioclinica
  • Ixico
  • Resonance Health
  • Radiant Sage
  • Intrinsic Imaging
  • Cardiovascular Imaging Technologies

Clinical Trial Imaging Market Insights

Lucintel forecasts that computed tomography will remain the largest segment over the forecast period due to including the increasing presence of contract research organizations (CROs) and rising research and development investments.

Within this market, pharmaceutical companies will remain the largest segment due to increasing demand for new treatments and medications aimed at addressing chronic diseases.

North America is expected to witness highest growth over the forecast period due to the presence of big outsourcing companies and an increase in r&d in the region. various factors such as the increasing geriatric population along with growing chronic diseases are projected to drive the market in north america. north america also performs the maximum number of clinical trials.

Features of the Global Clinical Trial Imaging Market

Market Size Estimates: Clinical trial imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clinical trial imaging market by various segments, such as by product & services, modality, therapeutic area, end use and region in terms of($B).

Regional Analysis: Clinical trial imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, modalities, therapeutic areas, end uses, and regions for the clinical trial imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clinical trial imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the clinical trial imaging market size?

Answer: The global clinical trial imaging market is expected to reach an estimated $2.1 billion by 2030.

Q.2 What is the growth forecast for clinical trial imaging market?

Answer: The global clinical trial imaging market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the clinical trial imaging market?

Answer: The major drivers for this market are increasing number of CROs, significantly growing pharmaceutical and biotechnology industries, and increasing R&D spending to discover drugs and therapies.

Q4. What are the major segments for clinical trial imaging market?

Answer: The future of the clinical trial imaging market looks promising with opportunities in the pharmaceutical company, biotechnology company, medical device manufacturer, contract research organization, academic and government research institute markets.

Q5. Who are the key clinical trial imaging market companies?

Answer: Some of the key clinical trial imaging companies are as follows:

  • ICON
  • Biotelemetry
  • Medpace Holdings
  • Biomedical Systems Corporation
  • Bioclinica
  • IXICO
  • Resonance Health
  • Radiant Sage
  • Intrinsic Imaging
  • Cardiovascular Imaging Technologies

Q6. Which clinical trial imaging market segment will be the largest in future?

Answer: Lucintel forecasts that computed tomography will remain the largest segment over the forecast period due to including the increasing presence of contract research organizations (CROs) and rising research and development investments.

Q7. In clinical trial imaging market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the presence of big outsourcing companies and an increase in r&d in the region. various factors such as the increasing geriatric population along with growing chronic diseases are projected to drive the market in north america. north america also performs the maximum number of clinical trials.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clinical trial imaging market by product & services (software and services), modality (computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, and echocardiography), therapeutic area (oncology, infectious diseases, neurology, CVS, endocrinology, and immunological disorder), end use (pharmaceutical companies, biotechnology companies, medical device manufacturer, contract research organizations, academic and government research institutes, and others),and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clinical Trial Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clinical Trial Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clinical Trial Imaging Market by Product & Services
    • 3.3.1: Software
    • 3.3.2: Services
  • 3.4: Global Clinical Trial Imaging Market by Modality
    • 3.4.1: Computed Tomography
    • 3.4.2: Magnetic Resonance Imaging
    • 3.4.3: Ultrasound
    • 3.4.4: Positron Emission Tomography
    • 3.4.5: X-ray
    • 3.4.6: Echocardiography
  • 3.5: Global Clinical Trial Imaging Market by Therapeutic Area
    • 3.5.1: Oncology
    • 3.5.2: Infectious Diseases
    • 3.5.3: Neurology
    • 3.5.4: CVS
    • 3.5.5: Endocrinology
    • 3.5.6: Immunological Disorder
  • 3.6: Global Clinical Trial Imaging Market by End Use
    • 3.6.1: Pharmaceutical Companies
    • 3.6.2: Biotechnology Companies
    • 3.6.3: Medical Device Manufacturer
    • 3.6.4: Contract Research Organizations
    • 3.6.5: Academic and Government Research Institutes
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clinical Trial Imaging Market by Region
  • 4.2: North American Clinical Trial Imaging Market
    • 4.2.2: North American Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
  • 4.3: European Clinical Trial Imaging Market
    • 4.3.1: European Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
    • 4.3.2: European Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
  • 4.4: APAC Clinical Trial Imaging Market
    • 4.4.1: APAC Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
    • 4.4.2: APAC Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
  • 4.5: ROW Clinical Trial Imaging Market
    • 4.5.1: ROW Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
    • 4.5.2: ROW Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clinical Trial Imaging Market by Product & Services
    • 6.1.2: Growth Opportunities for the Global Clinical Trial Imaging Market by Modality
    • 6.1.3: Growth Opportunities for the Global Clinical Trial Imaging Market by Therapeutic Area
    • 6.1.4: Growth Opportunities for the Global Clinical Trial Imaging Market by End Use
    • 6.1.5: Growth Opportunities for the Global Clinical Trial Imaging Market by Region
  • 6.2: Emerging Trends in the Global Clinical Trial Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clinical Trial Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Trial Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: ICON
  • 7.2: Biotelemetry
  • 7.3: Medpace Holdings
  • 7.4: Biomedical Systems Corporation
  • 7.5: Bioclinica
  • 7.6: IXICO
  • 7.7: Resonance Health
  • 7.8: Radiant Sage
  • 7.9: Intrinsic Imaging
  • 7.10: Cardiovascular Imaging Technologies